Clinical Trials Browser

Phase 2 × Neoplasms × copanlisib × Clear all

NCT03474744 2025-04-04

Copanlisib and Rituximab in Marginal Zone Lymphoma Patients

Phase 2 Active not recruiting

Neoplasms, Lymphoma, B-Cell, Marginal Zone